Medical director, Cellular Therapies Program
Mass General Brigham
Cambridge, Massachusetts, United States
OA1-AM24-TU-06 - A Novel Small Molecule Drug-Based Approach for Treating Beta-Globinopathies
Tuesday, October 22, 2024
8:30 AM - 10:00 AM
Disclosure(s): No financial relationships to disclose